These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8505148)

  • 1. Route of administration may determine the biological effects of RU 41,740 (Biostim). Trapping of 99mTc-labelled human albumin colloids in mice.
    Jacobsson H; Viland H; Blomgren H
    Int J Immunopharmacol; 1993 Apr; 15(3):353-60. PubMed ID: 8505148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Biostim (RU 41.740) on natural killer activity in different mouse organs.
    Sozzani S; Luini W; Braceschi L; Spreafico F
    Int J Immunopharmacol; 1986; 8(8):845-53. PubMed ID: 3804531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in the number and the phagocytic function of guinea pig pulmonary and peritoneal macrophages following oral administration of RU 41740, a glycoprotein extract from Klebsiella pneumoniae.
    Radermecker M; Rommain M; Maldague MP; Bury T; Smets P
    Int J Immunopharmacol; 1988; 10(8):913-7. PubMed ID: 3215709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostimulation of blood monocyte function by RU 41.740 (Biostim) in patients with chronic bronchitis.
    Nielsen H; Bonde J
    Int J Immunopharmacol; 1986; 8(6):589-92. PubMed ID: 3539830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of RU 41.740 on human monocytes in vitro: release of soluble factors which retard multiplication of tumor cells in culture.
    Blomgren H
    Int J Immunopharmacol; 1990; 12(1):99-105. PubMed ID: 2303322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human monocytes exposed to Biostim (RU 41740) alter lymphocyte mitogenesis: mechanisms of action.
    Viland H; Blomgren H
    Int J Immunopharmacol; 1988; 10(7):879-87. PubMed ID: 2466802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RU 41 740 (Biostim) and IL-4, or IL-13, have opposite effects on CD14, CD23, HLA-DR and HLA-DQ on monocytes.
    Garin L; Bernaud J; Picot N; Salvi M; Corallo F; Bloy C; Rigal D
    Int J Immunopharmacol; 1996 Jan; 18(1):69-74. PubMed ID: 8732434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness of human monocytes to Ru 41.740 (Biostim). Influence of preincubation in vitro.
    Blomgen H; Viland H
    Anticancer Res; 1991; 11(5):1849-53. PubMed ID: 1768055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of spontaneous cytotoxicity of human lymphocytes by RU 41.740 is due to monocyte-derived factors distinct from interleukin 2, interferon alpha and gamma.
    Viland H; Blomgren H
    Anticancer Res; 1987; 7(1):23-8. PubMed ID: 3105419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving bone marrow scintigraphy. A clinical and experimental study.
    Kalin B
    Acta Radiol Suppl; 1993; 385():1-24. PubMed ID: 8517188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of an immunomodulator, RU 41740, on experimental infections].
    Joly V
    Presse Med; 1988 Jul; 17(28):1430-2. PubMed ID: 2971180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of delayed cutaneous hypersensitivity by oral administration of RU 41740 (Biostim) in lymphoma patients--a randomized double blind multicentric trial.
    Lang JM; Gastaut JA; Sotto JJ; Troncy J; Marchiani C
    Int J Immunopharmacol; 1986; 8(7):687-90. PubMed ID: 3536765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the immunomodulator RU 41,740 (biostim) on the specific and nonspecific immunosuppression induced by thermal injury or protein deprivation.
    Christou NV; Zakaluzny I; Marshall JC; Nohr CW
    Arch Surg; 1988 Feb; 123(2):207-11. PubMed ID: 3124797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Double-blind study of an immunomodulator of bacterial origin (Biostim) in the prevention of infectious episodes in chronic bronchitis].
    Viallat JR; Costantini D; Boutin C; Farisse P
    Poumon Coeur; 1983; 39(1):53-7. PubMed ID: 6346306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral treatment with RU 41.740 (Biostim) in patients with advanced colorectal cancer: influence on the blood lymphocyte population.
    Blomgren H; Viland H; Cedermark B; Theve T; Ohman U
    Int J Immunopharmacol; 1989; 11(1):71-6. PubMed ID: 2707939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative study of guinea-pig bronchoalveolar cell population after oral administration of RU 41740 "Biostim".
    Rommain M; Brossard C; Smets P
    Ann Inst Pasteur Immunol; 1988; 139(5):581-5. PubMed ID: 3207469
    [No Abstract]   [Full Text] [Related]  

  • 17. Augmentation of spontaneous cytotoxicity of human lymphocytes by RU 41.740, a glucoprotein extract of Klebsiella pneumoniae.
    Viland H; Blomgren H
    Anticancer Res; 1987; 7(1):17-22. PubMed ID: 3494422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Biostim (RU-41740) on the expression of cytokine mRNAs in murine peritoneal macrophages in vitro.
    Meredith C; Scott MP; Pekelharing H; Miller K
    Toxicol Lett; 1990 Oct; 53(3):327-37. PubMed ID: 2237939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of RU 41740 aerosol treatment on mouse bronchoalveolar cells, and protection afforded against influenza virus infection.
    Michel F; Rudent A; Labarre C; Quero AM; Zalisz R; Smets P
    Int J Immunopharmacol; 1987; 9(7):775-81. PubMed ID: 2828252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ru 41.740 triggers human mononuclear blood cells to release tumor growth inhibitory factors in vitro.
    Blomgren H
    Int J Immunopharmacol; 1992 Feb; 14(2):185-90. PubMed ID: 1378044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.